Help Reduce the Risk of a Subsequent Stroke with AGGRENOX.
Watch videos from actual patients that relate to your condition.
Hear from a board-certified physician about FDA-approved Aggrenox® (aspirin/extended-release dipyridamole) 25 mg/200 mg capsules.
Learn how AGGRENOX may lower the risk of having another stroke.
AGGRENOX TESTIMONALS: Click to hear about AGGRENOX from a real patient or the doctor.
“I HAD A STROKE.”
After Bob had a stroke he learned he was at an increased risk of another stroke. Now, he’s taking AGGRENOX to help lower his risk.
Watch Bob’s Story
“I HAD A ‘MINI-STROKE’.”
Wally went to the doctor after experiencing symptoms of a “mini-stroke.” Now he can help lower his risk of another stroke with AGGRENOX.
Watch Wally’s Story
HEAR FROM A DOCTOR
Hear what Dr. Pappas has to say about lowering your risk of another stroke and how AGGRENOX may be able to help you.
Watch Video
This flash element is not visible because you do not have Adobe® Flash Player 9. Click here to download the latest version free of charge. This link is provided to you as a convenience. Boehringer Ingelheim Pharmaceuticals, Inc. does not control, and is not responsible for, the content of any linked page.
Important Safety Information
AGGRENOX is a prescription medication used to lower the risk of stroke in people who have had a “mini-stroke” (transient ischemia attack or TIA) or stroke due to a blood clot.
AGGRENOX should be avoided in patients allergic to any ingredient in AGGRENOX, allergic to non-steroidal anti-inflammatory drugs (NSAIDS), or who have the combination of asthma, runny nose and nasal polyps. AGGRENOX should not be given to a child or teenager due to the risk of Reye’s syndrome.
AGGRENOX may cause an increased bleeding risk, including into the brain, stomach or intestines and any bleeding may take longer to stop. AGGRENOX should be avoided in patients with a history of stomach ulcers or those who drink three or more alcoholic drinks a day due to the risk of bleeding. Patients should inform their doctor of all medications they are currently taking including NSAIDS or blood thinners.
AGGRENOX should be avoided during pregnancy, especially in the third trimester, or in patients with severe liver or kidney problems. The most common side effects of AGGRENOX are headache, upset stomach and diarrhea.
You are encouraged to report negative side effects of prescription drugs to the FDA.
Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
Click here for full Prescribing Information including Patient Information.
Content intended for U.S. residents only.
Copyright © 2011 Boehringer Ingelheim Pharmaceuticals, Inc. All rights reserved.
Use of this Site is subject to the Internet Site Legal Notices and Disclaimers and Privacy Policy.
AG87709CONS
